Hemodynamic effects of ethaverine hydrochloride in patients with peripheral vascular disease.
D001157:Arterial Occlusive Diseases / Q000503:physiopathology; D001794:Blood Pressure; D001916:Brachial Artery / Q000503:physiopathology; D005019:Ethyl Ethers / Q000494:pharmacology / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D009132:Muscles / Q000098:blood supply; D010208:Papaverine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D010991:Plethysmography; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply; D013997:Time Factors; D014652:Vascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D014655:Vascular Resistance / Q000187:drug effects
D005019:Ethyl Ethers; D007546:Isoquinolines; C007639:ethaverine; D010208:Papaverine